Showing 6,008 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Side effects

Updated Labeling for Efavirenz-Containing Products Warns of Possible Late-Onset Neurotoxicity

Editor's pick
Monthly Prescribing Reference
31 October 2019
Starting treatment

Weight gain on HIV treatment: more common with newer drugs, low CD4 counts

News
31 October 2019
Cardiovascular disease

Delaying HIV Treatment Linked to Stiffened Blood Vessels

Editor's pick
POZ
30 October 2019
Reproductive health

Women with HIV not at higher risk of blood pressure disorders in pregnancy

News
30 October 2019
Treatment interruptions

Pausing the pills: attitudes to treatment interruption

Editor's pick
HIV Cure
28 October 2019
Adherence

Medication lockers help Miami's homeless living with HIV

Editor's pick
Associated Press
28 October 2019
Kidney problems

Chronic kidney disease increases risk of numerous illnesses and death for people with HIV

News
23 October 2019
Low CD4 count

Two-Drug HIV Regimen Works Well Except in People With Low CD4 Count, Study Finds

Editor's pick
TheBodyPro
22 October 2019
Neurological & cognitive problems

Prevalence of self-reported neurocognitive impairment falls among people with HIV in Switzerland

News
22 October 2019
TB treatment

Dolutegravir-based regimen safe and effective for people taking rifampicin for TB

News
20 October 2019
Adherence

“They’re just making me feel worse”: beliefs about HIV treatment among African and Caribbean people living in the UK

News
18 October 2019
Ageing & HIV

Oldest known person with HIV dies at 100

Editor's pick
CTV News
17 October 2019
Retention & linkage to care

Half of people with HIV can start treatment on same day

News
16 October 2019
PrEP science

Switching to TAF-based PrEP improves kidney and bone markers – but does it raise cardiovascular risk?

News
15 October 2019
New & experimental HIV treatments

Oral cabotegravir and rilpivirine still effective at 312 weeks

News
14 October 2019
Retention & linkage to care

Rapid treatment start doesn't benefit all

News
9 October 2019
New & experimental HIV treatments

Ibalizumab monoclonal antibody is effective in real-world use

News
7 October 2019
Side effects

Do integrase inhibitors increase the risk of diabetes?

News
7 October 2019
Treatment guidelines

South Africa delays rollout of new blockbuster HIV drug dolutegravir

Editor's pick
Bhekisisa
7 October 2019
Side effects

Switching From TDF to TAF-Containing ART Carries BMI, Atherosclerotic Cardiovascular Disease Risk

Editor's pick
Contagion Live
7 October 2019
Injectable & long-acting HIV treatment

Women Find Long-Acting Injectable ART 'Emotionally Freeing and Empowering'

Editor's pick
Contagion Live
7 October 2019
Treatment simplification strategies

Some issues to consider with Dovato (dolutegravir + 3TC)

Editor's pick
CATIE
3 October 2019
PrEP science

Evaluating Microarray Patches for Long-Acting PrEP and Contraceptives

Editor's pick
Contagion Live
3 October 2019
New & experimental HIV treatments

European Commission Approves Trogarzo

Editor's pick
Global Newswire
27 September 2019